Naloxone Spray Market Size, Share, By Category (Branded, and Generic), Type (Prescription, and Over-the-Counter (OTC)), Dosage (2Mg/Actuation, 4Mg/Actuation, and Others), Age group (Pediatric, Adults, and Geriatric), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Region - Trends, Analysis, and Forecast till 2035

Naloxone spray market size was valued at USD 822 Billion in 2025 and is expected to reach USD 5783.4 Billion by 2035, growing at a CAGR of 23.9%

Rapid-acting, nasal-controversial naloxone spray is used to reverse the potentially fatal consequences of an opioid overdose, such as sluggish breathing and unconsciousness.

The growing opioid overdose issue, which has prompted extensive public health campaigns and government regulations aimed at expanding overdose reversal kits, is a major factor driving the expansion of the naloxone spray industry. Intranasal formulations are gaining popularity since they are needle-free, easy to use, pleasant, and quick to start, which helps hospital pharmacies sort and perform more efficiently. Naloxone sprays are also more affordable and readily accessible thanks to active regulatory backing (such as OTC approval), telemedicine platform development, improved insurance coverage, and intrusive pricing schemes including California's CalRx.